What we do?
We understand the importance of accurate and consistent data in the drug development process. Our SEND services make sures to deliver the SEND packages with quality.
1. Data Standardisation
Our skilled professionals are well-versed in CDISC standards and will transform your raw nonclinical data into compliant SEND datasets. We create SEND datasets for a variety of study types, including pharmacokinetic, toxicology, and safety studies.
2. Validation and Quality Control
Quality is our top priority. We perform rigorous validation checks on SEND datasets against FDA Business rules, FDA validation rules and CDISC Compliance rules to identify any inconsistencies, errors, or missing information. We conduct a thorough QC review against study reports to ensure that SEND datasets are consistent with the study report. Our quality control processes, guarantee that your data is accurate, reliable, and ready for regulatory submission.
3. Supported SENDIG Versions
Our expertise encompasses a range of SEND Implementation Guide (IG) versions, including:
- SENDIG 3.1 and 3.1.1
- SENDIG-Animal Rule v1.0
- SENDIG-DART v1.1 and v1.2
- SENDIG-Genetox v1.0
4. Custom Domain Support
We're equipped to handle data standardisation for domains that may currently required to be standardised in custom domains, such as:
- ADA (Anti-Drug Antibodies).
- Nervous System Findings.
- Dermal and Ocular Measurements.
5.Delivered SEND Package
When you choose us, your delivered SEND package includes:
- Standardised SEND datasets in SAS Transport Files (XPT format).
- Define.xml.
- Nonclinical Study Data Reviewer’s Guide (nsdrg).
- Pinnacle21 validation reports.